3 Value ETFs Beating the Market With 3 Very Different Playbooks

Value investing has regained leadership in 2026, with AVLV up 19.7% YTD and 38.0% over the past year, AVUV up 18.0% YTD and 37.1% over 12 months, and FNDX up 14.1% YTD and 31.5% over 12 months. The article argues higher-for-longer rates and a rotation away from mega-cap growth are supporting value, while highlighting three distinct implementations: quality-filtered large-cap value, deep-value small caps, and fundamental weighting. The piece is constructive on all three ETFs, but it is primarily an investment-style comparison rather than a catalyst-driven market event.

Analysis

The immediate beneficiary is not just the “value” factor but the market segment where cash flow is still legible under higher discount rates: profitable cyclicals, asset-light logistics, and selected industrials. The deeper second-order effect is that flows into these ETFs can mechanically support names with little narrative sponsorship, reducing dispersion only at the margin while extending the life of the trade in the most hated pockets of large- and small-cap U.S. equities. Among the disclosed holdings, VSAT, MATX, and LEA are being pulled higher less by idiosyncratic fundamentals than by a broader regime that rewards low expectations plus tangible earnings power.

The risk is that this is a late-cycle factor squeeze rather than a clean regime change. If rates roll over or mega-cap growth re-accelerates on earnings revisions, the valuation spread can close quickly and the factor premium can reverse over 4-8 weeks even if fundamentals do not deteriorate. Small-cap value is the most fragile: its upside is fastest in benign macro, but it is also the first place where credit stress, refinancing risk, or a growth scare would hit margins and multiples simultaneously.

Consensus is underestimating how much of the current strength is coming from rebalancing mechanics, not a permanent re-rating of cheap stocks. FNDX is the most durable expression because it buys strength and trims excess at rebalance; AVUV is the most crowded contrarian expression because everyone knows the small-cap/value payoff exists, but few can tolerate the path dependency. The cleaner trade is to own quality value exposure and avoid the weakest balance sheets that tend to get briefly promoted by factor screens before fundamentals catch up.

The names in the basket tell us the market is still paying for scarcity of credible earnings, not for cheapness alone. That argues for continued relative support in carriers, industrials, and selective energy services, but not for indiscriminate deep value. If earnings revisions turn less negative, the rally can continue for months; if not, the performance gap should narrow as soon as the macro tailwind fades.

Key Decisions for Investors

• Long AVLV vs. SPY for a 3-6 month window: best risk-adjusted way to own the value rotation with less trap exposure; target 8-12% relative outperformance, stop if growth leadership reasserts and AVLV underperforms by 4-5% on a rolling month.
• Pair trade AVUV long vs. IWM short only if you can hold 6-12 months: small-cap value has the highest upside convexity, but the short index leg helps monetize a re-rating away from unprofitable small caps; risk is a sharp rate-cut rally that squeezes both legs.
• Use FNDX as a core swap from SPY rather than an outright overweight: modest 2-4% incremental alpha potential over 12 months with lower tracking error than deep value; best for accounts that want factor tilt without style blowup.
• Short weakest secular expensive growth baskets against a value long only on rate-fade signals: if yields drift lower, value can still hold up while mega-cap multiple compression resumes; this is a cleaner expression than shorting the entire market.
• For single-name exposure, favor MATX and LEA over VSAT on a 3-9 month basis: the former two have more direct operating leverage to a value-friendly industrial/consumer repair cycle, while VSAT is more vulnerable to balance-sheet skepticism and delayed fundamental repair.